470 related articles for article (PubMed ID: 28295288)
1. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
2. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
3. High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma.
Luo K; Zhuang K
Biomed Pharmacother; 2017 Oct; 94():659-665. PubMed ID: 28787701
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
Ramis G; Villalonga-Planells R; Serra-Sitjar M; Brell M; Fernández de Mattos S; Villalonga P
Cell Oncol (Dordr); 2019 Aug; 42(4):521-536. PubMed ID: 30980364
[TBL] [Abstract][Full Text] [Related]
5. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
Zhang S; Liao K; Miao Z; Wang Q; Miao Y; Guo Z; Qiu Y; Chen B; Ren L; Wei Z; Lin Y; Lu X; Qiu Y
Neuro Oncol; 2019 Oct; 21(10):1284-1296. PubMed ID: 31504797
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
[TBL] [Abstract][Full Text] [Related]
8. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
[TBL] [Abstract][Full Text] [Related]
9. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
10. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
11. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
[TBL] [Abstract][Full Text] [Related]
12. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
13. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
15. High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.
Wang Y; Su Y; Ji Z; Lv Z
Med Sci Monit; 2018 Oct; 24():7556-7562. PubMed ID: 30348936
[TBL] [Abstract][Full Text] [Related]
16. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
17. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
18. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.
Li Y; He ZC; Zhang XN; Liu Q; Chen C; Zhu Z; Chen Q; Shi Y; Yao XH; Cui YH; Zhang X; Wang Y; Kung HF; Ping YF; Bian XW
Cancer Lett; 2018 Mar; 416():66-74. PubMed ID: 29196129
[TBL] [Abstract][Full Text] [Related]
19. FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation.
Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q
Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024
[TBL] [Abstract][Full Text] [Related]
20. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]